<DOC>
	<DOCNO>NCT00192972</DOCNO>
	<brief_summary>Both segmental , ostial circumferential , extra-ostial pulmonary vein ( PV ) isolation proven effective treatment atrial fibrillation . In study patient symptomatic paroxystic persistent AF randomise one mention ablation method . The primary endpoint recurrent AF recurrence leave atrium-PV conduction .</brief_summary>
	<brief_title>A Randomized Trial Ostial Versus Extra-Ostial Ablation Strategy Atrial Fibrillation</brief_title>
	<detailed_description>Both segmental , ostial circumferential , extra-ostial pulmonary vein ( PV ) isolation proven effective treatment atrial fibrillation . In study symptomativ paroxystic persistent AF randomise one mention ablation method . Each patient allow maximum two ablation procedure . Holter monitor 14-days period perform 3 month ablation . The patiens see out-patient visit 1 , 3 , 6 , 9 , 12 month ablation procedure . Primary endpoint recurrent AF recurrence leave atrium-PV conduction . Secondary endpoint : - safety - resumption LA-PV conduction - alteration neurohormone - socio-economics aspect ( cost effectiveness ) - change inflammatory marker - quality life - alteration signal average P wawe signal - evaluation predictive value variable predict recurrence AF</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>symptomatic paroxysmal persistent AF 6 month , least 3 episode 3 month insufficient effect least 2 pharmacological regimen congenital heart disease age 18 year significant valve disease leave atrial size &gt; 55 mm prior ablation AF Severe heart failure ( LVEF &lt; 20 % and/or NYHA class IV )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2003</verification_date>
	<keyword>Catheter ablation</keyword>
	<keyword>Atrial fibrillation</keyword>
</DOC>